Article
Medulloblastoma cell invasion is inhibited by green tea (−)epigallocatechin-3-gallate
Article first published online: 7 OCT 2003
DOI: 10.1002/jcb.10667
Copyright © 2003 Wiley-Liss, Inc.
Additional Information
How to Cite
Pilorget, A., Berthet, V., Luis, J., Moghrabi, A., Annabi, B. and Béliveau, R. (2003), Medulloblastoma cell invasion is inhibited by green tea (−)epigallocatechin-3-gallate. Journal of Cellular Biochemistry, 90: 745–755. doi: 10.1002/jcb.10667
Publication History
- Issue published online: 20 OCT 2003
- Article first published online: 7 OCT 2003
- Manuscript Accepted: 4 AUG 2003
- Manuscript Received: 23 JUN 2003
Funded by
- Cancer Research Society (to RB)
- Association pour la Recherche sur le Cancer
- Groupement des Entreprises Françaises dans la Lutte contre le Cancer
- Ligue Nationale contre le Cancer (to JL)
- Abstract
- Article
- References
- Cited By
Keywords:
- cell adhesion;
- migration;
- integrin;
- EGCG;
- green tea;
- medulloblastoma
Abstract
Epigallocatechin-3-gallate (EGCG), the major green tea polyphenol, can reach the brain following oral intake and could thus act as an anti-tumoral agent targeting several key steps of brain cancer cells invasive activity. Because integrin-mediated extracellular matrix recognition is crucial during the cell adhesion processes involved in carcinogenesis, we have investigated the effects of EGCG on different cellular integrins of the pediatric brain tumor-derived medulloblastoma cell line DAOY. Using flow cytometry, we report the levels of expression of several cell surface integrins in DAOY. These include high expression of α2, α3, and β1 integrins, as well as αv and β3 integrins. Moreover, we provide evidence that EGCG can antagonize DAOY cell migration specifically on collagen by increasing cell adhesive ability through specific gene and protein upregulation of the β1 integrin subunit. Our results suggest that this naturally occurring green tea polyphenol may thus be used as a nutraceutical therapeutic agent in targeting the invasive character of medulloblastomas. © 2003 Wiley-Liss, Inc.

1097-4644/asset/JCB_left.gif?v=1&s=fe954a25b77c41be79a8886f2a921df0f063e97e)
1097-4644/asset/cover.gif?v=1&s=c55ee036b3038496cb712d572571012ddd7c366c)